Home
Michael Thomas Henderson, CEO: Apogee Therapeutics APGE Sell · Filed 03/13
Trade details
- Type
- Insider sale
- Amount
- $621,287.27
- Shares · price
- 8,363 sh · $74.29 a share
- Held after
- 1,164,624 sh
- Trade date
- 26/03/11
- Filed
- 26/03/13
- Days to filing
- 2 days
Sold 0.7% of holdings
- Share of holding sold
- 0.7%
Apogee Therapeutics trades, last 26 weeks
What else happened in Apogee Therapeutics around then
Filed or reported within 30 days of the trade day · 02/09~04/10Michael Thomas Henderson's recent trades
- Michael Thomas Henderson
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 planApogee Therapeutics
APGE
$10.6M
80,000 sh
$10.6M
Filed 06/24
Traded 06/22
- Michael Thomas Henderson
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 planSpyre Therapeutics
SYRE
$2M
20,000 sh
$2M
Filed 06/23
Traded 06/22
- Michael Thomas Henderson
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 planSpyre Therapeutics
SYRE
$1.8M
20,000 sh
$1.8M
Filed 06/22
Traded 06/22
- Michael Thomas Henderson
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 planApogee Therapeutics
APGE
$633.6K
7,654 sh
$633.6K
Filed 06/12
Traded 06/10
- Michael Thomas Henderson
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 planApogee Therapeutics
APGE
$556.6K
6,770 sh
$556.6K
Filed 06/12
Traded 06/10
